Barclays lowered its price target while CMS determined excessive premiums for Centene Corporation.
2 reports, 2 independent
Updated Sep 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays lowered its price target while CMS determined excessive premiums for Centene Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
-
Centene Corporation
American multinational healthcare company
Nothing else this week.
-
Centers for Medicare and Medicaid Services
United States federal agency
Nothing else this week.
Related events
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
- Barclays dropped its target price on Pilgrim’s Pride shares on November 1, 2026.
- Barclays dropped its target price and set an underweight rating, while Cantor Fitzgerald also issued an underweight rating for Polestar.
Coverage
Newest first; wire copies grouped- StockStoryWhy Centene (CNC) Stock Is Down Today Shares of health coverage company Centene (NYSE:CNC) fell 5.4% in the afternoon session after Barclays significantly lowered its price target on the stock. Barcl
- Yahoo FinanceHealth insurance companies have a problem — people are using their plans more When medical insurance provider Centene (CNC) opened its books to investors on Friday, the company reported a surprising